Maha Katabi, Director, 10% Owner at Vera Therapeutics, Inc. (VERA), bought 2,914,776 shares at $11.00 ($8.0M) on 2021-05-18, disclosed to the SEC on 2021-05-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,187,504 | $0 | 0.0% |
| 2 | $11.00 | 727,272 | $8.0M | 100.0% |
| Total | $2.74 avg | 2,914,776 | $8.0M | 100% |
| Filing → |
| RYZB | BUY | 2023-09-21 | $4.2M | — | Filing → |
| VERA | BUY | 2022-02-14 | $4.0M | — | Filing → |
| AVTE | BUY | 2021-07-06 | $5.0M | — | Filing → |